Target-specific oral anticoagulants in patients undergoing cardioversion.

CONCLUSION: A limited body of published evidence suggests that dabigatran and apixaban may be effective alternatives to warfarin for anticoagulation therapy in patients with AF undergoing cardioversion. Careful consideration of the risks and benefits of TSOA versus warfarin use and patient preferences are key factors in appropriate drug selection.
PMID: 24973374 [PubMed - in process]

Source: American Journal of Health-System Pharmacy : AJHP - July 2, 2014 Category: Drugs & Pharmacology Authors: Law EH, Gordon W Tags: Am J Health Syst Pharm Source Type: research